NDC 13811-702 – Hydromorphone Hydrochloride
Hydromorphone Hydrochloride 12 mg/1 · Tablet, Extended Release · Oral
Product NDC13811-702
Product details
- Brand name
- Hydromorphone Hydrochloride
- Generic name
- Hydromorphone Hydrochloride
- Labeler
- Trigen Laboratories, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA205629
- Marketed since
- September 15, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Opioid Agonist
Active ingredients
- Hydromorphone Hydrochloride 12 mg/1
Uses, dosage, side effects and warnings for Hydromorphone Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 13811-702-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-702-10) | Sep 15, 2016 |
Other Hydromorphone Hydrochloride products
- 60687-566 Hydromorphone Hydrochloride 5 mg/5mL · Solution · American Health Packaging
- 60687-579 Hydromorphone Hydrochloride 2 mg/1 · Tablet · American Health Packaging
- 60687-590 Hydromorphone Hydrochloride 4 mg/1 · Tablet · American Health Packaging
- 43602-001 Hydromorphone Hydrochloride 5 mg/5mL · Solution · Ascent Pharmaceuticals Inc
- 43602-003 Hydromorphone Hydrochloride 4 mg/1 · Tablet · Ascent Pharmaceuticals Inc
- 43602-002 Hydromorphone Hydrochloride 2 mg/1 · Tablet · Ascent Pharmaceuticals Inc
- 43602-004 Hydromorphone Hydrochloride 8 mg/1 · Tablet · Ascent Pharmaceuticals Inc
- 87063-039 Hydromorphone Hydrochloride 8 mg/1 · Tablet · ASCLEMED USA INC.
- 87063-037 Hydromorphone Hydrochloride 2 mg/1 · Tablet · ASCLEMED USA INC.
- 87063-038 Hydromorphone Hydrochloride 4 mg/1 · Tablet · ASCLEMED USA INC.
- 13107-108 Hydromorphone Hydrochloride 4 mg/1 · Tablet · Aurolife Pharma, LLC
- 13107-109 Hydromorphone Hydrochloride 8 mg/1 · Tablet · Aurolife Pharma, LLC